<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Oncogene</journal-id>
    <journal-id journal-id-type="iso-abbrev">Oncogene</journal-id>
    <journal-title-group>
      <journal-title>Oncogene</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0950-9232</issn>
    <issn pub-type="epub">1476-5594</issn>
    <publisher>
      <publisher-name>Nature Publishing Group UK</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9076536</article-id>
    <article-id pub-id-type="pmid">35388171</article-id>
    <article-id pub-id-type="publisher-id">2286</article-id>
    <article-id pub-id-type="doi">10.1038/s41388-022-02286-x</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>eccDNAdb: a database of extrachromosomal circular DNA profiles in human cancers</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" corresp="yes" equal-contrib="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5358-6736</contrib-id>
        <name>
          <surname>Peng</surname>
          <given-names>Li</given-names>
        </name>
        <address>
          <email>pengli9@mail.sysu.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author" equal-contrib="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0393-316X</contrib-id>
        <name>
          <surname>Zhou</surname>
          <given-names>Nan</given-names>
        </name>
        <xref ref-type="aff" rid="Aff3">3</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Chao-Yang</given-names>
        </name>
        <xref ref-type="aff" rid="Aff5">5</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6063-7407</contrib-id>
        <name>
          <surname>Li</surname>
          <given-names>Guan-Cheng</given-names>
        </name>
        <xref ref-type="aff" rid="Aff6">6</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5376-3162</contrib-id>
        <name>
          <surname>Yuan</surname>
          <given-names>Xiao-Qing</given-names>
        </name>
        <address>
          <email>yuanxq7@mail.sysu.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff7">7</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.12981.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2360 039X</institution-id><institution>Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-Sen Memorial Hospital, </institution><institution>Sun Yat-Sen University, </institution></institution-wrap>Guangzhou, China </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.12981.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2360 039X</institution-id><institution>Medical Research Center, Sun Yat-Sen Memorial Hospital, </institution><institution>Sun Yat-Sen University, </institution></institution-wrap>Guangzhou, China </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.410737.6</institution-id><institution-id institution-id-type="ISNI">0000 0000 8653 1072</institution-id><institution>Department of Research, </institution><institution>The Affiliated Brain Hospital of Guangzhou Medical University, </institution></institution-wrap>Guangzhou, China </aff>
      <aff id="Aff4"><label>4</label>Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China </aff>
      <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.7497.d</institution-id><institution-id institution-id-type="ISNI">0000 0004 0492 0584</institution-id><institution>Division of Functional Genome Analysis, </institution><institution>German Cancer Research Center (DKFZ), </institution></institution-wrap>Heidelberg, Germany </aff>
      <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.216417.7</institution-id><institution-id institution-id-type="ISNI">0000 0001 0379 7164</institution-id><institution>Key Laboratory of Carcinogenesis of the Chinese Ministry of Health and the Key Laboratory of Carcinogenesis and Cancer Invasion of Chinese Ministry of Education, Cancer Research Institute, </institution><institution>Central South University, </institution></institution-wrap>Changsha, China </aff>
      <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.12981.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2360 039X</institution-id><institution>Breast Tumor Center, Sun Yat-sen Memorial Hospital, </institution><institution>Sun Yat-sen University, </institution></institution-wrap>Guangzhou, 510120 China </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>6</day>
      <month>4</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>6</day>
      <month>4</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="ppub">
      <year>2022</year>
    </pub-date>
    <volume>41</volume>
    <issue>19</issue>
    <fpage>2696</fpage>
    <lpage>2705</lpage>
    <history>
      <date date-type="received">
        <day>11</day>
        <month>10</month>
        <year>2021</year>
      </date>
      <date date-type="rev-recd">
        <day>9</day>
        <month>3</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>17</day>
        <month>3</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2022</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <p id="Par1"><bold>E</bold>xtra<bold>c</bold>hromosomal <bold>c</bold>ircular <bold>DNA</bold> (<bold>eccDNA</bold>) elements are circular DNA molecules that are derived from but are independent of chromosomal DNA. EccDNA is emerging as a rising star because of its ubiquitous existence in cancers and its crucial role in oncogene amplification and tumor progression. In the present study, whole-genome sequencing (WGS) data of cancer samples were downloaded from public repositories. Afterwards, eccDNAs were identified from WGS data via bioinformatic analyses. To leverage database coverage, eccDNAs were also collected by manual curation of literatures. Gene expression and clinical data were downloaded from TCGA and CCLE and then used to investigate the roles of eccDNAs in cancers. Finally, the first integrated database of eccDNAs, eccDNAdb, was developed. eccDNAdb currently includes 1270 eccDNAs, which were identified in 480 samples (of 42 cancers) after analyzing a total number of 3395 tumor samples (of 57 cancers) including patient tissues, patient-derived xenografts, and cancer cell lines. A total number of 54,901 eccDNA genes were annotated and included in the database as well. With the integration of gene expression, clinical information and chromatin accessibility data, eccDNAdb enables users to easily determine the biological function and clinical relevance of eccDNAs in human cancers. In conclusion, eccDNAdb is freely accessible at <ext-link ext-link-type="uri" xlink:href="http://www.eccdnadb.org">http://www.eccdnadb.org</ext-link>. To our knowledge, eccDNAdb is the first database in the eccDNA research field. It is expected to provide insight for novel cancer therapies.</p>
    </abstract>
    <kwd-group kwd-group-type="npg-subject">
      <title>Subject terms</title>
      <kwd>Epigenomics</kwd>
      <kwd>Predictive markers</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100003453</institution-id>
            <institution>Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation)</institution>
          </institution-wrap>
        </funding-source>
        <award-id>2019A1515012114</award-id>
        <award-id>2018A0303130329</award-id>
        <principal-award-recipient>
          <name>
            <surname>Peng</surname>
            <given-names>Li</given-names>
          </name>
          <name>
            <surname>Yuan</surname>
            <given-names>Xiao-Qing</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100002858</institution-id>
            <institution>China Postdoctoral Science Foundation</institution>
          </institution-wrap>
        </funding-source>
        <award-id>2019M663254</award-id>
        <principal-award-recipient>
          <name>
            <surname>Peng</surname>
            <given-names>Li</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>National Natural Science Foundation of China (grant no. 81972658 to L. Peng), Guangdong Basic and Applied Basic Research Foundation (grant no. 2018A030313129 to L. Peng), National Postdoctoral Program for Innovation Talents (grant no. BX20190395 to L. Peng), and the Fundamental Research Funds for the Central Universities (grant no. 20ykpy105 to L. Peng)</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001809</institution-id>
            <institution>National Natural Science Foundation of China (National Science Foundation of China)</institution>
          </institution-wrap>
        </funding-source>
        <award-id>81803636</award-id>
        <principal-award-recipient>
          <name>
            <surname>Yuan</surname>
            <given-names>Xiao-Qing</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© Springer Nature Limited 2022</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par2">Nuclear DNA is packaged into 23 pairs of linear chromosomes. Researchers have long observed the existence of <bold>e</bold>xtra<bold>c</bold>hromosomal <bold>c</bold>ircular <bold>DNA</bold> (<bold>eccDNA</bold>) elements [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. EccDNAs are derived from chromosomes but are independent of chromosomal DNA [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. Unlike chromosomal amplicons, eccDNAs follow a nonchromosomal mechanism of inheritance: because they lack centromeres, eccDNAs are segregated unequally into daughter cells; thus, daughter cells can have a higher eccDNA copy number than the parental cells [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. This unique mechanism of inheritance enables eccDNAs to change rapidly with the environment [<xref ref-type="bibr" rid="CR6">6</xref>]. These observations demonstrate that eccDNAs undoubtedly exist, but these results were obtained before the advent of human genome sequencing technology. Computational analysis of high-throughput sequencing datasets offers a new perspective on eccDNAs in the genomic landscape of tumors.</p>
    <p id="Par3">Recently, through high-throughput sequencing, eccDNAs were found to exist more ubiquitously in human cancers, including glioblastoma, neuroblastoma, and breast cancer, than previously anticipated [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. eccDNA is a driver of eukaryotic genome plasticity and is involved in numerous biological processes [<xref ref-type="bibr" rid="CR9">9</xref>]. Turner et al. noted that oncogene amplification, which drives tumor progression and intratumoral heterogeneity, is prevalent on eccDNAs [<xref ref-type="bibr" rid="CR5">5</xref>]. Intratumoral heterogeneity induces chemotherapeutic resistance, and cancer cells can evade therapies that target oncogenes maintained on eccDNAs [<xref ref-type="bibr" rid="CR10">10</xref>]. Moreover, eccDNAs drive the transcription of numerous oncogenes, including MYC, EGFR and CDK4, by increasing DNA copy numbers [<xref ref-type="bibr" rid="CR7">7</xref>] and chromatin accessibility and enabling ultra-long-range chromatin contacts to promote cancer growth [<xref ref-type="bibr" rid="CR4">4</xref>]. Two recent studies highlighted the association of eccDNAs with poor clinical prognosis in multiple cancers, including neuroblastoma [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Clearly, the above studies indicated that amplification of eccDNA genes plays a crucial role in intratumoral heterogeneity, drug resistance and cancer progression. Revealing the underlying mechanism may broaden the horizon for targeted disruption of key oncogenes currently considered undruggable. Thus, eccDNA and eccDNA genes have great potential as treatment targets to prevent the progression and even the occurrence of cancers and as biomarkers for cancer diagnosis or prognostic prediction.</p>
    <p id="Par4">Thanks to this renewed understanding, there is an urgent need for a database to study the biological properties of eccDNAs and, more importantly, to facilitate eccDNA-based techniques for cancer treatment and prognosis prediction. Here, we developed the first integrated database of eccDNAs, eccDNAdb, which aims to identify known and novel eccDNAs in human cancers by computational analysis of whole-genome sequencing (WGS) data and to annotate and illustrate the potential roles of these eccDNAs in human cancers.</p>
  </sec>
  <sec id="Sec2" sec-type="results">
    <title>Results</title>
    <sec id="Sec3">
      <title>Statistics of eccDNAdb data</title>
      <p id="Par5">In total, 1270 eccDNAs were identified, with 754 from WGS data and 516 from literature curation. EccDNAs were found in most studied cancers, demonstrating its ubiquitous existence in human cancers (Supplementary Table <xref rid="MOESM4" ref-type="media">S2</xref>). Brain cancers, including glioblastoma, glioma, and lower grade glioma, had the most eccDNAs, while biliary tract cancer, oral cancer and thyroid cancer had the fewest. Most cancers had more than 5 eccDNAs (Fig. <xref rid="Fig1" ref-type="fig">1A</xref>). EccDNAs were identified on all chromosomes (Fig. <xref rid="Fig1" ref-type="fig">1B</xref>) and eccDNAs had a size ranging from 21 bp to 1 Gb (Fig. <xref rid="Fig1" ref-type="fig">1C</xref>). Approximately, one-fourth of the eccDNAs were &lt;3.2 kb, half of the eccDNAs were &lt;282 kb, and 75% of the eccDNAs were &lt;2.5 Mb in size. The average eccDNA size was 9.4 Mb (Fig. <xref rid="Fig1" ref-type="fig">1C</xref>). The eccDNAs were composed of 1 to 99 segments, but most (61.26%) had only one segment (Fig. <xref rid="Fig1" ref-type="fig">1D</xref>). One-fourth of the eccDNAs were composed of three or more segments (Fig. <xref rid="Fig1" ref-type="fig">1D</xref>). For those eccDNAs identified from WGS data: eccDNA copy counts ranged from 1 to 160; mean copy count was 11.51; half of the eccDNAs had a copy count between 4 and 15; and nearly 30% of the eccDNAs had a copy count of &lt;2 or &gt;15 (Fig. <xref rid="Fig1" ref-type="fig">1E</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><title>Statistics of eccDNAs in eccDNAdb.</title><p><bold>A</bold> Distribution of eccDNAs in human cancers. <bold>B</bold> Distribution of eccDNA segments in chromosomes. <bold>C</bold> Distribution of eccDNA sizes. <bold>D</bold> Distribution of eccDNA segment numbers. <bold>E</bold> Distribution of eccDNA copy counts.</p></caption><graphic xlink:href="41388_2022_2286_Fig1_HTML" id="d32e529"/></fig></p>
      <p id="Par6">In total, 54901 genes were annotated as eccDNA genes (Supplementary Table <xref rid="MOESM5" ref-type="media">S3</xref>). The number of genes varied among eccDNAs, with an average of 7 genes per eccDNA (Fig. <xref rid="Fig2" ref-type="fig">2A</xref>). Approximately 85.83% of eccDNAs had at least 1 gene (Fig. <xref rid="Fig2" ref-type="fig">2A</xref>). More than ten eccDNA genes were found in most cancers, except for colon cancer, renal cancer and thyroid cancer (Fig. <xref rid="Fig2" ref-type="fig">2B</xref>). The most eccDNA genes were identified in pancreatic cancer. EccDNA genes were distributed on all chromosomes (Fig. <xref rid="Fig2" ref-type="fig">2C</xref>; Supplementary Table <xref rid="MOESM6" ref-type="media">S4</xref>). ConsensusPathDB [<xref ref-type="bibr" rid="CR12">12</xref>] pathway analysis showed that these genes were enriched in biological processes including gene expression, transcription, estrogen signaling, GPCR signaling and so on (Fig. <xref rid="Fig2" ref-type="fig">2D</xref>). The distributions of eccDNA and eccDNA gene number by chromosomes were listed in Supplementary Table <xref rid="MOESM7" ref-type="media">S5</xref>.<fig id="Fig2"><label>Fig. 2</label><caption><title>Statistics of eccDNA gene.</title><p><bold>A</bold> Frequency distribution relationship of eccDNA genes and eccDNAs. <bold>B</bold> Distribution of eccDNA genes in human cancers. <bold>C</bold> Distribution of eccDNA genes in chromosomes. <bold>D</bold> ConsensusPathDB pathway analysis of eccDNA genes in human cancers.</p></caption><graphic xlink:href="41388_2022_2286_Fig2_HTML" id="d32e581"/></fig></p>
    </sec>
    <sec id="Sec4">
      <title>Database description</title>
      <p id="Par7">The database homepage provides a succinct introduction, a welcome message, and the development workflow. The navigation bar contains links for all resources in the database (Fig. <xref rid="Fig3" ref-type="fig">3A</xref>). On the “Browse” page, eccDNAs are listed in a table by row, and the information associated with the eccDNA is shown in the columns (Fig. <xref rid="Fig3" ref-type="fig">3B</xref>). In the top right corner of the table, there is a search box that can be used to filter content in the table. Clicking on the ID of an eccDNA will open its detail page, which is described in detail later in the “Database utility” section. The search process in eccDNAdb is straightforward, and various search strategies are provided (Fig. <xref rid="Fig3" ref-type="fig">3C–G</xref>). To submit data to eccDNAdb, the submit form on the submit page can be used (Fig. <xref rid="Fig3" ref-type="fig">3H</xref>). Regarding feedback, users are encouraged to send their suggestions to us via the feedback form on the contact page (Fig. <xref rid="Fig3" ref-type="fig">3I</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><title>Overview of eccDNAdb.</title><p><bold>A</bold> Navigation bar. <bold>B</bold> “Browse” page of eccDNAs. <bold>C</bold>–<bold>G</bold> “Search” pages. <bold>H</bold> “Submit” form. <bold>I</bold> “Contact” form.</p></caption><graphic xlink:href="41388_2022_2286_Fig3_HTML" id="d32e630"/></fig></p>
    </sec>
  </sec>
  <sec id="Sec5">
    <title>Database utility</title>
    <p id="Par8">In this section, we mainly describe the “Browse”, “Search”, and “GB” modules and demonstrate how to utilize eccDNAdb with examples.</p>
    <sec id="Sec6">
      <title>Browse</title>
      <p id="Par9">All eccDNAs identified in this study can be accessed via the “Browse” link. In the data table on the “Browse” page, eccDNA entries are listed in rows, and eccDNA features are displayed in columns. Of note, a copy count of −1 in the “Copy count” column means this type of data is not available. The “ID” column shows the eccDNAdb ID of each eccDNA. The ID of an eccDNA is formatted as A_B_C_D, where (i) A is the origin of the species, (ii) B is the origin and number of the host chromosome(s), (iii) C is the number of segments, and (iv) D is the inclusion order of eccDNAs with the same designators for A, B, and C. Specifically, only data derived from humans were used in this study; thus, A is uniformly represented by “hsa”. B is represented by “Chr” plus a number or by a number plus “Chr”. The former format indicates that the eccDNA is derived from only one chromosome, and the number indicates the chromosome number; the latter format means that the eccDNA is derived from multiple chromosomes, and the number indicates the number of chromosomes. C is represented by a number plus “S”. “S” represents the word “segment”, and the number indicates the number of segments contained in the eccDNA. D is a random designator representing the order in which we assigned IDs to eccDNAs with the same designators for A, B, and C. D is always 1 if the A_B_C designator is not duplicated. Three eccDNA IDs are presented as examples: hsa_Chr20_6S_1 indicates that this eccDNA is derived from human chromosome 20 and consists of six segments; hsa_4Chr_9S_1 denotes a eccDNA that is derived from four distinct chromosomes and composed of nine segments; hsa_2Chr_8S_2 indicates that this eccDNA is derived from two human chromosomes, is composed of eight segments, and is the second eccDNA assigned the same hsa_2Chr_8S designator.</p>
      <p id="Par10">The eccDNA ID in the table is clickable. Clicking on the ID of an eccDNA opens its detail page. The information on the detail page is organized in separate sections. The “Basic information” section shows a basic description of the eccDNA, which is the same as the content on the “Browse” page.</p>
      <p id="Par11">After the “Basic information” section, structures of the eccDNA and amplicon are shown. The eccDNA structure is shown as a circular plot, and it also possesses interactive features. The inner circle of the plot shows the copy count of the eccDNA. The copy count appears when the mouse cursor moves on the layer. The outer circle shows the eccDNA segments and segment labels. Segment details will show up when moving mouse cursor onto it. A segment label is composed of a digital number and “&gt;” or “&lt;” symbols. The number indicates the segment order, and the “&gt;” and “&lt;” symbols denote the directions of the eccDNA segments. The directional symbols offer users a clear picture of how genomic segments are connected to form the eccDNA.</p>
      <p id="Par12">In the “eccDNA gene list” section, eccDNA genes are listed in a table. Clicking on a gene row will pick up the gene and show it in the following “eccDNA gene selector” panel. The “Pan-cancer eccDNA gene expression profile (TCGA)” and “Pan-cancer eccDNA gene expression profile (CCLE)” sections show the expression profiles of eccDNA genes in patient tissues and cancer cells, respectively. The “eccDNA gene expression in Tumor vs. Normal” section shows box plots of eccDNA genes’ expression in tumor vs. normal samples. In the box plot, <italic>p</italic>-values calculated by Student’s <italic>t</italic> test are shown in parentheses next to gene name on the x-axis. The “eccDNA gene in pan-cancer prognosis” section shows the survival analysis results for patients stratified by mean and median eccDNA gene expression levels. Near the bottom of the detail page, eccDNA gene-gene interaction network is shown in the section of “Interaction network of eccDNA genes”.</p>
    </sec>
    <sec id="Sec7">
      <title>Search</title>
      <sec id="Sec8">
        <title>Search by eccDNA</title>
        <p id="Par13">We use “hsa_Chr7_3S_1” as an example to show the information provided by eccDNAdb. When “hsa_Chr7_3S_1” is inputted as a keyword, eccDNAdb returns available information about this eccDNA: “ID”, “Segments”, “Unique genes”, “Copy count”, “Sample type”, “Tissue”, “Disease”, and “Cell line”. When the link to this eccDNA is clicked, its detail page appears. On the detail page, we can see “Segments” as “1 chr7:55222713–55676816+ 2 chr7:55677806–56117062+ 3 chr7:54830972–55194959+” and “Disease” as “Glioblastoma” in the “Basic information” section. The eccDNA plot is shown following basic information (Fig. <xref rid="Fig4" ref-type="fig">4A</xref>). When the cursor moves onto a segment in the outer ring of the circular plot of eccDNA hsa_Chr7_3S_1, more information about this segment is revealed (Supplementary Fig. <xref rid="MOESM2" ref-type="media">S1A</xref>). The inner ring shows the copy count (here, 100.25) of the eccDNA in glioblastoma (Supplementary Fig. <xref rid="MOESM2" ref-type="media">S1B</xref>). The list of eccDNA genes belonging to hsa_Chr7_3S_1 is shown as Supplementary Fig. <xref rid="MOESM2" ref-type="media">S1C</xref>. If the user is interested in the expression rank of any genes in a TCGA cohort (such as glioblastoma), the expression profile can be found in the “Pan-cancer eccDNA gene expression profile (TCGA)” section (Fig. <xref rid="Fig4" ref-type="fig">4B</xref>). Gene expression ranks in cancer cell lines can be found in the “Pan-cancer eccDNA gene expression profile (CCLE)” section (Supplementary Fig. <xref rid="MOESM2" ref-type="media">S1D</xref>). Moreover, eccDNA gene expression differences between tumor and normal groups in TCGA cohorts can be found in the “eccDNA gene expression in Tumor vs. Normal” section (Fig. <xref rid="Fig4" ref-type="fig">4C</xref>). Further, we might wonder whether these eccDNA genes are associated with cancer prognosis. We can find that among the hsa_Chr7_3S_1 genes, high expression of EGFR indicates poor prognosis of LGG (Fig. <xref rid="Fig4" ref-type="fig">4D</xref>). Additionally, interactions of hsa_Chr7_3S_1 genes are visualized in the “Interaction network of eccDNA genes” section (Supplementary Fig. <xref rid="MOESM2" ref-type="media">S1E</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><title>Introduction to eccDNA detail page.</title><p><bold>A</bold> Circular structure of hsa_Chr7_3S_1 in eccDNAdb. <bold>B</bold> Expression rank of hsa_Chr7_3S_1′s eccDNA gene in human glioblastoma (TCGA-GBM). <bold>C</bold> Comparison of hsa_Chr7_3S_1′s eccDNA gene expression between tumor and normal groups in glioblastoma (TCGA-GBM). <bold>D</bold> Overall survival differences between low grade glioma (TCGA-LGG) patients stratified by mean EGFR expression. <bold>E</bold> Chromatin accessibility of eccDNA-containing region chr7:54370001–55996000 in two glioblastoma samples.</p></caption><graphic xlink:href="41388_2022_2286_Fig4_HTML" id="d32e713"/></fig></p>
      </sec>
      <sec id="Sec9">
        <title>Search by gene</title>
        <p id="Par14">On the page of “Search by Gene”, either gene symbol or gene location can be used to search eccDNAs. For example, entering ELDR in the search box would find all eccDNAs to which this gene belongs. In the result table, eccDNAs are listed by row, with columns showing ID, segments, unique genes, copy count, sample type, tissue, disease, and cell line. Clicking on an ID will open the detail page of indicated eccDNA.</p>
      </sec>
      <sec id="Sec10">
        <title>Search by cancer</title>
        <p id="Par15">On the page of “Search by Cancer”, either cancer or disease name can be used to search eccDNAs. For example, entering “acute myeloid leukemia” in the search box would find all eccDNAs identified in this cancer. In the result table, eccDNAs are listed by row, with columns showing ID, segments, unique genes, copy count, sample type, tissue, disease, and cell line. Clicking on an ID will open the detail page of indicated eccDNA.</p>
      </sec>
      <sec id="Sec11">
        <title>Search by tissue or sample type</title>
        <p id="Par16">On the “Search by Tissue or Sample Type” page, either the tissue name or sample type can be used to search eccDNAs. For example, entering “brain” or “cancer PDX” in the search box finds all eccDNAs in the corresponding tissue or sample. In the results table, eccDNAs are listed in the rows, with the columns showing ID, segments, unique genes, copy count, sample type, tissue, disease, and cell line. Clicking on an ID opens the detail page for the indicated eccDNA.</p>
      </sec>
    </sec>
    <sec id="Sec12">
      <title>Chromatin accessibility of eccDNAs</title>
      <p id="Par17">To determine the chromatin accessibility of eccDNA-containing genomic region, open chromatin regions across the genome were identified in assay for transposase-accessible chromatin with sequencing (ATAC-seq) data. ATAC-seq data were integrated, and a genome browser was provided for easy use of this feature. On the “GB” page, available ATAC-seq datasets are listed by cancer on the left. Clicking on the cancer name expands the viewport, and BigWig tracks are shown. The selected reference sequence, annotations, eccDNA segments, and ATAC-seq data are shown as tracks on the genome browser viewport. Users can use genome browser handlers to easily select and view the genomic region of interest.</p>
      <p id="Par18">We take EGFR and GBM as an example to describe how to use the “GB” feature. First, we check “GRCh37-hg19”, “ENCODE genes” and “eccDNA segments” boxes on the left of the genome browser. Then, we click “GBM_bigwigs” to expand this menu. After that, we input “EGFR” in the text box at the top of the genome browser viewport and click “Go”. The results show that chromatin is highly accessible at the EGFR gene locus and indicate its mapping eccDNA in GBM (Fig. <xref rid="Fig4" ref-type="fig">4E</xref>).</p>
    </sec>
  </sec>
  <sec id="Sec13" sec-type="discussion">
    <title>Discussion</title>
    <p id="Par19">To our knowledge, eccDNAdb is the first integrated database of eccDNAs identified by the analysis of WGS data and literature curation. Interest in eccDNA elements is increasing because of their ubiquity and important roles in human cancers. EccDNAdb will facilitate eccDNA research in different ways. (i) A landscape of eccDNAs in human cancers is provided. The data we analyzed were derived from 3395 samples across 57 tumor types. (ii) The eccDNAs in eccDNAdb were carefully annotated. Database users can easily retrieve eccDNA structure, eccDNA gene, eccDNA gene expression profile, differentially expressed eccDNA gene, and cancer prognosis. This knowledge facilitates the understanding of why an eccDNA or eccDNA gene is important in cancer biology, thus providing insight for the development of novel cancer therapies. (iii) Database users can search eccDNAdb in multiple ways. Currently, searches by eccDNA, gene, cancer, tissue, and sample type are available. In addition, chromatin accessibility data of eccDNA-containing genomic regions in primary human cancers is provided in eccDNAdb. These features are very useful for finding the information that database users are interested in. Through large-scale WGS data analysis, eccDNAdb will allow a more comprehensive understanding of cancer etiologies from new perspectives and lay foundations for new therapeutics and impactful clinical trials.</p>
    <p id="Par20">EccDNAs exist more ubiquitously than expected in human cancers. They drive massive amplification of genes, leading to high gene expression. With an estimation of 19,292,789 new cases and 9,958,133 deaths in 2020 [<xref ref-type="bibr" rid="CR13">13</xref>], cancer is a high incidence and leading cause of death worldwide. In the United States, ~1,898,160 cancer cases were expected to be diagnosed and 608,570 deaths from cancer were expected to occur in 2021 [<xref ref-type="bibr" rid="CR14">14</xref>]. The overall clinical outcomes of patients are poor in many cancers and vary considerably among cancers and individuals. A recent study showed that oncogenes contained by eccDNA can predict unfavorable prognoses for cancer patients [<xref ref-type="bibr" rid="CR8">8</xref>]. In eccDNAdb, associations between the overall survival of cancer patients and expression level of eccDNA genes are provided. Many eccDNA genes are indeed correlated with the clinical survival of cancer patients, as shown in our database.</p>
    <p id="Par21">ATAC-seq is a method for identifying open chromatin regions [<xref ref-type="bibr" rid="CR15">15</xref>–<xref ref-type="bibr" rid="CR19">19</xref>]. Corces et al. provided the genome-wide chromatinic accessibility profiles of 410 tumor samples across 23 cancer types from TCGA [<xref ref-type="bibr" rid="CR20">20</xref>]. Chromatin accessibility, a hallmark of activated DNA modulation elements, plays a crucial role in linking the gene expression spectrum with epigenetic changes and ultimately influences the outcome of clinical treatment of cancer. EccDNA has been reported to exhibit higher chromatin accessibility and active chromatin state than chromosomal DNA, and this property is linked to higher transcription level of eccDNA [<xref ref-type="bibr" rid="CR4">4</xref>]. In our database, the ATAC-seq data of 23 cancers were downloaded from the TCGA database. These data are shown on the “GB” page and combined with annotations of eccDNA and eccDNA genes. These integrated ATAC-seq and eccDNA data provide users with information on the chromatin regulatory landscape of eccDNA in primary human cancers.</p>
    <p id="Par22">Currently, there are four high-throughput methods for systematic identification of eccDNAs: WGS [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR11">11</xref>], Circularization for In vitro Reporting of CLeavage Effects by sequencing (CIRCLE-seq) [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>], circular DNA enrichment sequencing (CIDER-Seq) [<xref ref-type="bibr" rid="CR23">23</xref>] and ATAC-seq [<xref ref-type="bibr" rid="CR24">24</xref>]. CIRCLE-seq is a technique for evaluating genomic off-target mutations induced by CRISPR-Cas9 editing [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. CIDER-Seq is a novel method to generate accurate eccDNA sequences and circular viral DNA sequences [<xref ref-type="bibr" rid="CR23">23</xref>]. These two methods are anticipated to be rising stars for eccDNA research. However, a few sequencing data of these techniques are currently available. As mentioned above, ATAC-seq is usually used to identify open chromatin regions, and Kumar et al. found that it can detect eccDNA from tumor at the preamplification stage [<xref ref-type="bibr" rid="CR24">24</xref>]. Unquestionably, the WGS technique has been used in more studies than other techniques and is reported in more scientific literature [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. AmpliconArchitect is a robust and feasible tool for detecting eccDNA elements from WGS data [<xref ref-type="bibr" rid="CR25">25</xref>]. Therefore, in this study, we systematically identified eccDNAs in human cancers by analysis of WGS data using AmpliconArchitect. Meanwhile, manual curation of eccDNAs from published articles was also performed to increase the database coverage.</p>
    <p id="Par23">In the future, we will continuously update eccDNAdb with newly published data and data submitted by users. Additional eccDNAs confirmed by low-throughput experiments or identified by other methods, such as CIDER-Seq [<xref ref-type="bibr" rid="CR23">23</xref>], will be recorded in eccDNAdb to overcome current limitation that all eccDNAs in the database were identified by the AmpliconArchitect pipeline. In addition, more genetic and epigenetic information related to eccDNAs will be integrated. Numerous eccDNAs have been found in other organisms, including plants [<xref ref-type="bibr" rid="CR26">26</xref>–<xref ref-type="bibr" rid="CR28">28</xref>], yeast [<xref ref-type="bibr" rid="CR29">29</xref>–<xref ref-type="bibr" rid="CR31">31</xref>], kinetoplastids [<xref ref-type="bibr" rid="CR32">32</xref>], <italic>Saccharomyces cerevisiae</italic> [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>], <italic>Drosophila</italic> [<xref ref-type="bibr" rid="CR35">35</xref>], <italic>Xenopus laevis</italic> [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>], and <italic>Mus musculus</italic> [<xref ref-type="bibr" rid="CR38">38</xref>]. Hence, more species and diseases will be considered in future updates.</p>
  </sec>
  <sec id="Sec14" sec-type="conclusion">
    <title>Conclusions</title>
    <p id="Par24">In summary, eccDNAdb, the first integrated database of eccDNAs, is a comprehensive catalog of eccDNAs identified in human cancers by computational analysis of WGS data and by manual literature curation. EccDNA genes were identified and annotated with expression data from TCGA and CCLE databases. The database provides not only basic information about eccDNAs but also the prognostic value of eccDNA genes. Meanwhile, ATAC-seq data from TCGA were integrated for the exploration of eccDNA’s chromatin accessibility. It is expected that the database will deepen our understanding of the mechanisms of eccDNAs in cancer development and facilitate eccDNA research.</p>
  </sec>
  <sec id="Sec15" sec-type="materials|methods">
    <title>Materials and methods</title>
    <sec id="Sec16">
      <title>Data collection</title>
      <p id="Par25">WGS data of 183 tumor samples and 8 normal samples (Supplementary Table <xref rid="MOESM3" ref-type="media">S1</xref>) were downloaded from the NCBI SRA database. First, low-coverage (&lt;5×) WGS data of 131 samples (123 tumor and 8 normal), originally generated by Turner et al. [<xref ref-type="bibr" rid="CR5">5</xref>] were downloaded from SRA study SRP081035. Second, high-coverage (&gt;5×) WGS data of 44 tumor samples were collected and downloaded from SRA. To find high-coverage data for different types of human cancers, a reference list of cancer types was created according to the major primary cancer sites included in the TCGA database, and the SRA database was then searched with the reference cancer types as a search term. Considering biological significance and computation speed, no more than three high-coverage SRA runs per cancer type were downloaded and analyzed in this study. For cancers that had more than three SRA runs, three runs were randomly selected for analysis. Third, WGS data of 16 samples of cancer cells generated by the CCLE project (PRJNA523380) were downloaded from SRA. Finally, the low- and high-coverage WGS data and CCLE data were combined into a single WGS dataset for further analysis.</p>
      <p id="Par26">In order to make our database comprehensive, we also performed manual curation of literatures to collect eccDNAs that are identified using AmpliconArchitect and readily available, in addition to ab inito analysis of WGS data. Eventually, we collected 516 eccDNAs from the article published by Kim et al. [<xref ref-type="bibr" rid="CR8">8</xref>] who generated the results after analyzing 3212 patient samples (Supplementary Table <xref rid="MOESM3" ref-type="media">S1</xref>).</p>
    </sec>
    <sec id="Sec17">
      <title>EccDNA identification from WGS data</title>
      <p id="Par27">WGS reads were mapped to the human reference genome hg19 with BWA [<xref ref-type="bibr" rid="CR39">39</xref>]. Copy number variations (CNVs) were identified with ReadDepth using default parameters [<xref ref-type="bibr" rid="CR40">40</xref>]. Notably, sex chromosomes were eliminated from the analysis because ReadDepth regards them as entirely deleted in males. CNVs with copy number &gt;5 and size &gt;100 kb were selected and merged into seed intervals with amplified_intervals.py, and amplicons were further identified with AmpliconArchitect.py in the AmpliconArchitect software suite [<xref ref-type="bibr" rid="CR25">25</xref>]. We considered copy number &gt;5 by referring to Deshpande et al.’s study who investigated CNV of matched tumor and normal cases from TCGA and found this as the criterion to identify somatically amplified intervals [<xref ref-type="bibr" rid="CR25">25</xref>]. Default settings of AmpliconArchitect were used during the analysis. After amplicon detection, eccDNAs were extracted from cycle files by converting amplicon cycle data into eccDNA data via in-house scripts. Because a cycle in the cycle file can also be reconstructed without the determined endpoint, such a cycle is in fact a linear contig and will not be selected as an eccDNA.</p>
      <p id="Par28">Normal samples were used as a control for the detection of eccDNA in tumors. CNVs of eight normal samples were obtained. The set of amplified intervals for normal samples were created and then marked as blacklisted regions. Afterwards, tumor intervals overlapping blacklisted regions were trimmed to exclude the portions within 1 Mbp of the blacklist regions [<xref ref-type="bibr" rid="CR25">25</xref>].</p>
    </sec>
    <sec id="Sec18">
      <title>Annotation of eccDNA genes</title>
      <p id="Par29">Genes that entirely or partially overlap with one or multiple eccDNAs are defined as eccDNA genes. To identify eccDNA gene, comprehensive gene annotation was downloaded from the GENCODE database (GRCh37 version of release 38). Then, BedTools intersect was used to find overlaps between eccDNA and GENCODE gene [<xref ref-type="bibr" rid="CR41">41</xref>]. Overlap size, namely the number of intersecting bases, was recorded and subsequently used to calculate the overlap ratios for eccDNA and gene, respectively. The eccDNA ratio (<italic>R</italic><sub><italic>e</italic></sub>) was calculated as the overlap size divided by the eccDNA size, i.e., <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$R_e \,=\, \frac{{Overlap\,size}}{{eccDNA\,size}}$$\end{document}</tex-math><mml:math id="M2"><mml:mrow><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mspace width="0.25em"/><mml:mo>=</mml:mo><mml:mspace width="0.25em"/><mml:mfrac><mml:mrow><mml:mi>O</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>l</mml:mi><mml:mi>a</mml:mi><mml:mi>p</mml:mi><mml:mspace width="0.25em"/><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>z</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:mi>c</mml:mi><mml:mi>D</mml:mi><mml:mi>N</mml:mi><mml:mi>A</mml:mi><mml:mspace width="0.25em"/><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>z</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math><inline-graphic xlink:href="41388_2022_2286_Article_IEq1.gif"/></alternatives></inline-formula>, while the gene ratio (<italic>R</italic><sub><italic>g</italic></sub>) was calculated as the overlap size divided by the gene size, i.e., <inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$R_g \,=\, \frac{{Overlap\,size}}{{Gene\,size}}$$\end{document}</tex-math><mml:math id="M4"><mml:mrow><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mspace width="0.25em"/><mml:mo>=</mml:mo><mml:mspace width="0.25em"/><mml:mfrac><mml:mrow><mml:mi>O</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>l</mml:mi><mml:mi>a</mml:mi><mml:mi>p</mml:mi><mml:mspace width="0.25em"/><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>z</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>G</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mspace width="0.25em"/><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>z</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math><inline-graphic xlink:href="41388_2022_2286_Article_IEq2.gif"/></alternatives></inline-formula>. Overlap ratio ranges between 0 and 1, with 0 indicating no intersection between two queried features while 1 indicating one feature entirely overlaps with the other. For example, a gene ratio of 1 means this gene completely resides in the queried eccDNA.</p>
    </sec>
    <sec id="Sec19">
      <title>Expression of eccDNA genes</title>
      <p id="Par30">To examine the expression of eccDNA genes in human cancers, data for gene expression in patient samples and cancer cells were downloaded from TCGA via the GDC Data Portal (<ext-link ext-link-type="uri" xlink:href="https://portal.gdc.cancer.gov/">https://portal.gdc.cancer.gov/</ext-link>) and CCLE (<ext-link ext-link-type="uri" xlink:href="https://portals.broadinstitute.org/ccle">https://portals.broadinstitute.org/ccle</ext-link>), respectively. EccDNA gene expression was analyzed at two levels: (i) a detailed expression profile of eccDNA genes in each cancer; and (ii) a comparison of gene expression levels between normal and tumor samples. Two-tailed <italic>t</italic> test was performed in Python to determine differences between the normal and tumor groups.</p>
    </sec>
    <sec id="Sec20">
      <title>Survival analysis</title>
      <p id="Par31">To analyze the prognostic value of eccDNA genes in human cancers, clinical information was also downloaded from TCGA via the GDC Data Portal (<ext-link ext-link-type="uri" xlink:href="https://portal.gdc.cancer.gov/">https://portal.gdc.cancer.gov/</ext-link>). The mean or median expression levels of eccDNA genes were used to stratify cancer patients. Given an eccDNA gene, patients with an expression level below the mean or median value were defined as the low expression group, and those with an expression level above the mean or median value were defined as the high expression group. The lifelines library in Python was then used to analyze the effect of eccDNA genes on cancer prognosis.</p>
    </sec>
    <sec id="Sec21">
      <title>Database implementation</title>
      <p id="Par32">The database was developed with modern web programming languages such as HTML5 and CSS3. Bootstrap v4 (<ext-link ext-link-type="uri" xlink:href="https://getbootstrap.com/">https://getbootstrap.com/</ext-link>) was used to design the layout of the user interface. DataTables (<ext-link ext-link-type="uri" xlink:href="https://datatables.net/">https://datatables.net/</ext-link>) was used to show tabular data on the webpages. jQuery (<ext-link ext-link-type="uri" xlink:href="https://jquery.com/">https://jquery.com/</ext-link>) was used for enhanced interactive functionality. The circosJS (<ext-link ext-link-type="uri" xlink:href="https://github.com/nicgirault/circosJS">https://github.com/nicgirault/circosJS</ext-link>) library was used to visualize eccDNA structures on the webpage. The Plotly graphing library (<ext-link ext-link-type="uri" xlink:href="https://plotly.com/">https://plotly.com/</ext-link>) was used for dynamically rendering graphs on the webpage. Data were stored in an SQLite (<ext-link ext-link-type="uri" xlink:href="https://www.sqlitetutorial.net/">https://www.sqlitetutorial.net/</ext-link>) database. The STRING database API was used to construct interaction network of eccDNA genes [<xref ref-type="bibr" rid="CR42">42</xref>]. The web application was developed with the Django (<ext-link ext-link-type="uri" xlink:href="http://djangoproject.com/">http://djangoproject.com/</ext-link>) framework. The website was deployed in the Alibaba Cloud in an ECS host running Ubuntu 18.04 and Apache2.</p>
    </sec>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary information</title>
    <sec id="Sec22">
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="41388_2022_2286_MOESM1_ESM.docx">
            <caption>
              <p>Legends of supplemental Figure S1 and Table S1-S5</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM2">
          <media xlink:href="41388_2022_2286_MOESM2_ESM.pdf">
            <caption>
              <p>supplemental Figure S1</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM3">
          <media xlink:href="41388_2022_2286_MOESM3_ESM.xlsx">
            <caption>
              <p>supplemental Table S1</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM4">
          <media xlink:href="41388_2022_2286_MOESM4_ESM.xlsx">
            <caption>
              <p>supplemental Table S2</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM5">
          <media xlink:href="41388_2022_2286_MOESM5_ESM.xlsx">
            <caption>
              <p>supplemental Table S3</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM6">
          <media xlink:href="41388_2022_2286_MOESM6_ESM.xlsx">
            <caption>
              <p>supplemental Table S4</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM7">
          <media xlink:href="41388_2022_2286_MOESM7_ESM.xlsx">
            <caption>
              <p>supplemental Table S5</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <fn-group>
    <fn>
      <p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
    <fn>
      <p>These authors contributed equally: Li Peng, Nan Zhou.</p>
    </fn>
  </fn-group>
  <sec>
    <title>Supplementary information</title>
    <p>The online version contains supplementary material available at 10.1038/s41388-022-02286-x.</p>
  </sec>
  <ack>
    <title>Acknowledgements</title>
    <p>We are grateful for WGS data from NCBI SRA and CCLE database, for RNA-seq data from CCLE database, and for the RNA-seq and ATAC-seq datasets from TCGA project team. This research was supported in part through computational resources provided by Bioinformatics Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Author contributions</title>
    <p>LP and XY conceived the project. NZ and LP analyzed the data. XY and NZ designed the database. LP, XY, and NZ wrote the paper. CZ and GL help to collect the data and revise the paper. All authors read and approved the final paper.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This work was supported in part by the National Natural Science Foundation of China (grant no. 81972658 and 81802812 to LP, grant no. 81803636 to XQY), Guangdong Basic and Applied Basic Research Foundation (grant no. 2019A1515012114 and 2018A030313129 to LP, grant no. 2018A0303130329 to XQY), National Postdoctoral Program for Innovation Talents (grant no. BX20190395 to LP), China Postdoctoral Science Foundation (grant no. 2019M663254 to LP), and the Fundamental Research Funds for the Central Universities (grant no. 20ykpy105 to LP). Also, this work was supported in part by Basic and Applied Basic Research of Guangzhou Municipal Basic Research Plan (No. 202102020742); Science and Technology Plan Project of Guangdong Province (No. 2019B030316001); Guangzhou Municipal Key Discipline in Medicine (2021–2023).</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Data availability</title>
    <p>All data generated or analyzed during this study are included in this published article and its <xref rid="MOESM1" ref-type="media">Supplementary Information</xref> files.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Code availability</title>
    <p>The source code for the identification of eccDNAs and for the annotation of eccDNA genes is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/solo7773/eccDNAdb">https://github.com/solo7773/eccDNAdb</ext-link>.</p>
  </notes>
  <notes id="FPar1" notes-type="COI-statement">
    <title>Competing interests</title>
    <p id="Par33">The authors declare no competing interests.</p>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hotta</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Bassel</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Molecular size and circularity of DNA in cells of mammals and higher plants</article-title>
        <source>Proc Natl Acad Sci USA</source>
        <year>1965</year>
        <volume>53</volume>
        <fpage>356</fpage>
        <lpage>62</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.53.2.356</pub-id>
        <?supplied-pmid 14294069?>
        <pub-id pub-id-type="pmid">14294069</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cox</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Yuncken</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Spriggs</surname>
            <given-names>AI</given-names>
          </name>
        </person-group>
        <article-title>Minute chromatin bodies in malignant tumours of childhood</article-title>
        <source>Lancet</source>
        <year>1965</year>
        <volume>1</volume>
        <fpage>55</fpage>
        <lpage>8</lpage>
        <pub-id pub-id-type="doi">10.1016/S0140-6736(65)90131-5</pub-id>
        <?supplied-pmid 14304929?>
        <pub-id pub-id-type="pmid">14304929</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Cell-free eccDNAs: a new type of nucleic acid component for liquid biopsy?</article-title>
        <source>Mol Diagn Ther</source>
        <year>2018</year>
        <volume>22</volume>
        <fpage>515</fpage>
        <lpage>22</lpage>
        <pub-id pub-id-type="doi">10.1007/s40291-018-0348-6</pub-id>
        <?supplied-pmid 29959693?>
        <pub-id pub-id-type="pmid">29959693</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Turner</surname>
            <given-names>KM</given-names>
          </name>
          <name>
            <surname>Nguyen</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Raviram</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Erb</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Santini</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Circular ecDNA promotes accessible chromatin and high oncogene expression</article-title>
        <source>Nature</source>
        <year>2019</year>
        <volume>575</volume>
        <fpage>699</fpage>
        <lpage>703</lpage>
        <pub-id pub-id-type="doi">10.1038/s41586-019-1763-5</pub-id>
        <?supplied-pmid 31748743?>
        <pub-id pub-id-type="pmid">31748743</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Turner</surname>
            <given-names>KM</given-names>
          </name>
          <name>
            <surname>Deshpande</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Beyter</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Koga</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Rusert</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity</article-title>
        <source>Nature</source>
        <year>2017</year>
        <volume>543</volume>
        <fpage>122</fpage>
        <lpage>5</lpage>
        <pub-id pub-id-type="doi">10.1038/nature21356</pub-id>
        <?supplied-pmid 28178237?>
        <pub-id pub-id-type="pmid">28178237</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Verhaak</surname>
            <given-names>RGW</given-names>
          </name>
          <name>
            <surname>Bafna</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Mischel</surname>
            <given-names>PS</given-names>
          </name>
        </person-group>
        <article-title>Extrachromosomal oncogene amplification in tumour pathogenesis and evolution</article-title>
        <source>Nat Rev Cancer</source>
        <year>2019</year>
        <volume>19</volume>
        <fpage>283</fpage>
        <lpage>8</lpage>
        <pub-id pub-id-type="doi">10.1038/s41568-019-0128-6</pub-id>
        <?supplied-pmid 30872802?>
        <pub-id pub-id-type="pmid">30872802</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Morton</surname>
            <given-names>AR</given-names>
          </name>
          <name>
            <surname>Dogan-Artun</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Faber</surname>
            <given-names>ZJ</given-names>
          </name>
          <name>
            <surname>MacLeod</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Bartels</surname>
            <given-names>CF</given-names>
          </name>
          <name>
            <surname>Piazza</surname>
            <given-names>MS</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Functional enhancers shape extrachromosomal oncogene amplifications</article-title>
        <source>Cell</source>
        <year>2019</year>
        <volume>179</volume>
        <fpage>1330</fpage>
        <lpage>41.e13</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2019.10.039</pub-id>
        <?supplied-pmid 31761532?>
        <pub-id pub-id-type="pmid">31761532</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Nguyen</surname>
            <given-names>NP</given-names>
          </name>
          <name>
            <surname>Turner</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Gujar</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>Luebeck</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers</article-title>
        <source>Nat Genet</source>
        <year>2020</year>
        <volume>52</volume>
        <fpage>891</fpage>
        <lpage>7</lpage>
        <pub-id pub-id-type="doi">10.1038/s41588-020-0678-2</pub-id>
        <?supplied-pmid 32807987?>
        <pub-id pub-id-type="pmid">32807987</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yerlici</surname>
            <given-names>VT</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>MW</given-names>
          </name>
          <name>
            <surname>Hoge</surname>
            <given-names>CR</given-names>
          </name>
          <name>
            <surname>Miller</surname>
            <given-names>RV</given-names>
          </name>
          <name>
            <surname>Neme</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Khurana</surname>
            <given-names>JS</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Programmed genome rearrangements in Oxytricha produce transcriptionally active extrachromosomal circular DNA</article-title>
        <source>Nucleic Acids Res</source>
        <year>2019</year>
        <volume>47</volume>
        <fpage>9741</fpage>
        <lpage>60</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkz725</pub-id>
        <?supplied-pmid 31504770?>
        <pub-id pub-id-type="pmid">31504770</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nathanson</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Gini</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Mottahedeh</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Visnyei</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Koga</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Gomez</surname>
            <given-names>G</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA</article-title>
        <source>Science</source>
        <year>2014</year>
        <volume>343</volume>
        <fpage>72</fpage>
        <lpage>6</lpage>
        <pub-id pub-id-type="doi">10.1126/science.1241328</pub-id>
        <?supplied-pmid 24310612?>
        <pub-id pub-id-type="pmid">24310612</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Koche</surname>
            <given-names>RP</given-names>
          </name>
          <name>
            <surname>Rodriguez-Fos</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Helmsauer</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Burkert</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>MacArthur</surname>
            <given-names>IC</given-names>
          </name>
          <name>
            <surname>Maag</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastoma</article-title>
        <source>Nat Genet</source>
        <year>2020</year>
        <volume>52</volume>
        <fpage>29</fpage>
        <lpage>34</lpage>
        <pub-id pub-id-type="doi">10.1038/s41588-019-0547-z</pub-id>
        <?supplied-pmid 31844324?>
        <pub-id pub-id-type="pmid">31844324</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kamburov</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Stelzl</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Lehrach</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Herwig</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>The ConsensusPathDB interaction database: 2013 update</article-title>
        <source>Nucleic Acids Res</source>
        <year>2013</year>
        <volume>41</volume>
        <fpage>D793</fpage>
        <lpage>800</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gks1055</pub-id>
        <?supplied-pmid 23143270?>
        <pub-id pub-id-type="pmid">23143270</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sung</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Ferlay</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Siegel</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Laversanne</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Soerjomataram</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Jemal</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title>
        <source>CA Cancer J Clin</source>
        <year>2021</year>
        <volume>71</volume>
        <fpage>209</fpage>
        <lpage>49</lpage>
        <pub-id pub-id-type="doi">10.3322/caac.21660</pub-id>
        <?supplied-pmid 33538338?>
        <pub-id pub-id-type="pmid">33538338</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Siegel</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Miller</surname>
            <given-names>KD</given-names>
          </name>
          <name>
            <surname>Fuchs</surname>
            <given-names>HE</given-names>
          </name>
          <name>
            <surname>Jemal</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Cancer statistics, 2021</article-title>
        <source>CA Cancer J Clin</source>
        <year>2021</year>
        <volume>71</volume>
        <fpage>7</fpage>
        <lpage>33</lpage>
        <pub-id pub-id-type="doi">10.3322/caac.21654</pub-id>
        <?supplied-pmid 33433946?>
        <pub-id pub-id-type="pmid">33433946</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gorkin</surname>
            <given-names>DU</given-names>
          </name>
          <name>
            <surname>Barozzi</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>AY</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>An atlas of dynamic chromatin landscapes in mouse fetal development</article-title>
        <source>Nature</source>
        <year>2020</year>
        <volume>583</volume>
        <fpage>744</fpage>
        <lpage>51</lpage>
        <pub-id pub-id-type="doi">10.1038/s41586-020-2093-3</pub-id>
        <?supplied-pmid 32728240?>
        <pub-id pub-id-type="pmid">32728240</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Markenscoff-Papadimitriou</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Whalen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Przytycki</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Thomas</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Binyameen</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Nowakowski</surname>
            <given-names>TJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A Chromatin accessibility atlas of the developing human telencephalon</article-title>
        <source>Cell</source>
        <year>2020</year>
        <volume>182</volume>
        <fpage>754</fpage>
        <lpage>69.e18</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2020.06.002</pub-id>
        <?supplied-pmid 32610082?>
        <pub-id pub-id-type="pmid">32610082</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Adam</surname>
            <given-names>RC</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Ge</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Infarinato</surname>
            <given-names>NR</given-names>
          </name>
          <name>
            <surname>Gur-Cohen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Miao</surname>
            <given-names>Y</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>NFI transcription factors provide chromatin access to maintain stem cell identity while preventing unintended lineage fate choices</article-title>
        <source>Nat Cell Biol</source>
        <year>2020</year>
        <volume>22</volume>
        <fpage>640</fpage>
        <lpage>50</lpage>
        <pub-id pub-id-type="doi">10.1038/s41556-020-0513-0</pub-id>
        <?supplied-pmid 32393888?>
        <pub-id pub-id-type="pmid">32393888</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ding</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Liang</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Kang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Xue</surname>
            <given-names>Y</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Smarca5 mediated epigenetic programming facilitates fetal HSPC development in vertebrates</article-title>
        <source>Blood</source>
        <year>2021</year>
        <volume>137</volume>
        <fpage>190</fpage>
        <lpage>202</lpage>
        <pub-id pub-id-type="doi">10.1182/blood.2020005219</pub-id>
        <?supplied-pmid 32756943?>
        <pub-id pub-id-type="pmid">32756943</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Link</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Wiese</surname>
            <given-names>CB</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Avetisyan</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Ronquillo</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>F</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>X chromosome dosage of histone demethylase KDM5C determines sex differences in adiposity</article-title>
        <source>J Clin Investig</source>
        <year>2020</year>
        <volume>130</volume>
        <fpage>5688</fpage>
        <lpage>702</lpage>
        <pub-id pub-id-type="doi">10.1172/JCI140223</pub-id>
        <?supplied-pmid 32701509?>
        <pub-id pub-id-type="pmid">32701509</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Corces</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Granja</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Shams</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Louie</surname>
            <given-names>BH</given-names>
          </name>
          <name>
            <surname>Seoane</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>W</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The chromatin accessibility landscape of primary human cancers</article-title>
        <source>Science.</source>
        <year>2018</year>
        <volume>362</volume>
        <fpage>eaav1898.</fpage>
        <pub-id pub-id-type="doi">10.1126/science.aav1898</pub-id>
        <?supplied-pmid 30361341?>
        <pub-id pub-id-type="pmid">30361341</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tsai</surname>
            <given-names>SQ</given-names>
          </name>
          <name>
            <surname>Nguyen</surname>
            <given-names>NT</given-names>
          </name>
          <name>
            <surname>Malagon-Lopez</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Topkar</surname>
            <given-names>VV</given-names>
          </name>
          <name>
            <surname>Aryee</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Joung</surname>
            <given-names>JK</given-names>
          </name>
        </person-group>
        <article-title>CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR-Cas9 nuclease off-targets</article-title>
        <source>Nat Methods</source>
        <year>2017</year>
        <volume>14</volume>
        <fpage>607</fpage>
        <lpage>14</lpage>
        <pub-id pub-id-type="doi">10.1038/nmeth.4278</pub-id>
        <?supplied-pmid 28459458?>
        <pub-id pub-id-type="pmid">28459458</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lazzarotto</surname>
            <given-names>CR</given-names>
          </name>
          <name>
            <surname>Nguyen</surname>
            <given-names>NT</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Malagon-Lopez</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Aryee</surname>
            <given-names>MJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Defining CRISPR-Cas9 genome-wide nuclease activities with CIRCLE-seq</article-title>
        <source>Nat Protoc</source>
        <year>2018</year>
        <volume>13</volume>
        <fpage>2615</fpage>
        <lpage>42</lpage>
        <pub-id pub-id-type="doi">10.1038/s41596-018-0055-0</pub-id>
        <?supplied-pmid 30341435?>
        <pub-id pub-id-type="pmid">30341435</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mehta</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Cornet</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Hirsch-Hoffmann</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Zaidi</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Vanderschuren</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Full-length sequencing of circular DNA viruses and extrachromosomal circular DNA using CIDER-Seq</article-title>
        <source>Nat Protoc</source>
        <year>2020</year>
        <volume>15</volume>
        <fpage>1673</fpage>
        <lpage>89</lpage>
        <pub-id pub-id-type="doi">10.1038/s41596-020-0301-0</pub-id>
        <?supplied-pmid 32246135?>
        <pub-id pub-id-type="pmid">32246135</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kumar</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Kiran</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Saha</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Su</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Paulsen</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Chatrath</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>ATAC-seq identifies thousands of extrachromosomal circular DNA in cancer and cell lines</article-title>
        <source>Sci Adv</source>
        <year>2020</year>
        <volume>6</volume>
        <fpage>eaba2489</fpage>
        <pub-id pub-id-type="doi">10.1126/sciadv.aba2489</pub-id>
        <?supplied-pmid 32440553?>
        <pub-id pub-id-type="pmid">32440553</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Deshpande</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Luebeck</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Nguyen</surname>
            <given-names>ND</given-names>
          </name>
          <name>
            <surname>Bakhtiari</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Turner</surname>
            <given-names>KM</given-names>
          </name>
          <name>
            <surname>Schwab</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Exploring the landscape of focal amplifications in cancer using AmpliconArchitect</article-title>
        <source>Nat Commun</source>
        <year>2019</year>
        <volume>10</volume>
        <fpage>392</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-018-08200-y</pub-id>
        <?supplied-pmid 30674876?>
        <pub-id pub-id-type="pmid">30674876</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Navrátilová</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Koblízková</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Macas</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Survey of extrachromosomal circular DNA derived from plant satellite repeats</article-title>
        <source>BMC Plant Biol</source>
        <year>2008</year>
        <volume>8</volume>
        <fpage>90</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2229-8-90</pub-id>
        <?supplied-pmid 18721471?>
        <pub-id pub-id-type="pmid">18721471</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cohen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Houben</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Segal</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Extrachromosomal circular DNA derived from tandemly repeated genomic sequences in plants</article-title>
        <source>Plant J Cell Mol Biol</source>
        <year>2008</year>
        <volume>53</volume>
        <fpage>1027</fpage>
        <lpage>34</lpage>
        <pub-id pub-id-type="doi">10.1111/j.1365-313X.2007.03394.x</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lanciano</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Carpentier</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Llauro</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Jobet</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Robakowska-Hyzorek</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Lasserre</surname>
            <given-names>E</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Sequencing the extrachromosomal circular mobilome reveals retrotransposon activity in plants</article-title>
        <source>PLoS Genet</source>
        <year>2017</year>
        <volume>13</volume>
        <fpage>e1006630</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1006630</pub-id>
        <?supplied-pmid 28212378?>
        <pub-id pub-id-type="pmid">28212378</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sinclair</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Guarente</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Extrachromosomal rDNA circles–a cause of aging in yeast</article-title>
        <source>Cell</source>
        <year>1997</year>
        <volume>91</volume>
        <fpage>1033</fpage>
        <lpage>42</lpage>
        <pub-id pub-id-type="doi">10.1016/S0092-8674(00)80493-6</pub-id>
        <?supplied-pmid 9428525?>
        <pub-id pub-id-type="pmid">9428525</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Møller</surname>
            <given-names>HD</given-names>
          </name>
          <name>
            <surname>Parsons</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Jørgensen</surname>
            <given-names>TS</given-names>
          </name>
          <name>
            <surname>Botstein</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Regenberg</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>Extrachromosomal circular DNA is common in yeast</article-title>
        <source>Proc Natl Acad Sci USA</source>
        <year>2015</year>
        <volume>112</volume>
        <fpage>E3114</fpage>
        <lpage>22</lpage>
        <?supplied-pmid 26038577?>
        <pub-id pub-id-type="pmid">26038577</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hull</surname>
            <given-names>RM</given-names>
          </name>
          <name>
            <surname>King</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Pizza</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Krueger</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Vergara</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Houseley</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Transcription-induced formation of extrachromosomal DNA during yeast ageing</article-title>
        <source>PLoS Biol</source>
        <year>2019</year>
        <volume>17</volume>
        <fpage>e3000471</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pbio.3000471</pub-id>
        <?supplied-pmid 31794573?>
        <pub-id pub-id-type="pmid">31794573</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Alsford</surname>
            <given-names>NS</given-names>
          </name>
          <name>
            <surname>Navarro</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Jamnadass</surname>
            <given-names>HR</given-names>
          </name>
          <name>
            <surname>Dunbar</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Ackroyd</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Murphy</surname>
            <given-names>NB</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The identification of circular extrachromosomal DNA in the nuclear genome of Trypanosoma brucei</article-title>
        <source>Mol Microbiol</source>
        <year>2003</year>
        <volume>47</volume>
        <fpage>277</fpage>
        <lpage>89</lpage>
        <pub-id pub-id-type="doi">10.1046/j.1365-2958.2003.03266.x</pub-id>
        <?supplied-pmid 12519183?>
        <pub-id pub-id-type="pmid">12519183</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Møller</surname>
            <given-names>HD</given-names>
          </name>
          <name>
            <surname>Larsen</surname>
            <given-names>CE</given-names>
          </name>
          <name>
            <surname>Parsons</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Hansen</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Regenberg</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Mourier</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Formation of extrachromosomal circular DNA from long terminal repeats of retrotransposons in Saccharomyces cerevisiae</article-title>
        <source>G3</source>
        <year>2015</year>
        <volume>6</volume>
        <fpage>453</fpage>
        <lpage>62</lpage>
        <pub-id pub-id-type="doi">10.1534/g3.115.025858</pub-id>
        <?supplied-pmid 26681518?>
        <pub-id pub-id-type="pmid">26681518</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Prada-Luengo</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Møller</surname>
            <given-names>HD</given-names>
          </name>
          <name>
            <surname>Henriksen</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Larsen</surname>
            <given-names>CE</given-names>
          </name>
          <name>
            <surname>Alizadeh</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Replicative aging is associated with loss of genetic heterogeneity from extrachromosomal circular DNA in Saccharomyces cerevisiae</article-title>
        <source>Nucleic Acids Res</source>
        <year>2020</year>
        <volume>48</volume>
        <fpage>7883</fpage>
        <lpage>98</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa545</pub-id>
        <?supplied-pmid 32609810?>
        <pub-id pub-id-type="pmid">32609810</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cohen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Yacobi</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Segal</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Extrachromosomal circular DNA of tandemly repeated genomic sequences in Drosophila</article-title>
        <source>Genome Res</source>
        <year>2003</year>
        <volume>13</volume>
        <fpage>1133</fpage>
        <lpage>45</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.907603</pub-id>
        <?supplied-pmid 12799349?>
        <pub-id pub-id-type="pmid">12799349</pub-id>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cohen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Méchali</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Formation of extrachromosomal circles from telomeric DNA in Xenopus laevis</article-title>
        <source>EMBO Rep</source>
        <year>2002</year>
        <volume>3</volume>
        <fpage>1168</fpage>
        <lpage>74</lpage>
        <pub-id pub-id-type="doi">10.1093/embo-reports/kvf240</pub-id>
        <?supplied-pmid 12446568?>
        <pub-id pub-id-type="pmid">12446568</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cohen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Menut</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Méchali</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Regulated formation of extrachromosomal circular DNA molecules during development in Xenopus laevis</article-title>
        <source>Mol Cell Biol</source>
        <year>1999</year>
        <volume>19</volume>
        <fpage>6682</fpage>
        <lpage>9</lpage>
        <pub-id pub-id-type="doi">10.1128/MCB.19.10.6682</pub-id>
        <?supplied-pmid 10490607?>
        <pub-id pub-id-type="pmid">10490607</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tsuda</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Yamagishi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Ohnishi</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Yamada</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Izumi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Mori</surname>
            <given-names>KJ</given-names>
          </name>
        </person-group>
        <article-title>Extrachromosomal circular DNAs from murine hemopoietic tissue cells</article-title>
        <source>Plasmid</source>
        <year>1983</year>
        <volume>10</volume>
        <fpage>235</fpage>
        <lpage>41</lpage>
        <pub-id pub-id-type="doi">10.1016/0147-619X(83)90037-9</pub-id>
        <?supplied-pmid 6657775?>
        <pub-id pub-id-type="pmid">6657775</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Durbin</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Fast and accurate short read alignment with Burrows-Wheeler transform</article-title>
        <source>Bioinformatics</source>
        <year>2009</year>
        <volume>25</volume>
        <fpage>1754</fpage>
        <lpage>60</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btp324</pub-id>
        <?supplied-pmid 19451168?>
        <pub-id pub-id-type="pmid">19451168</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Miller</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Hampton</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Coarfa</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Milosavljevic</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>ReadDepth: a parallel R package for detecting copy number alterations from short sequencing reads</article-title>
        <source>PLoS ONE</source>
        <year>2011</year>
        <volume>6</volume>
        <fpage>e16327</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0016327</pub-id>
        <?supplied-pmid 21305028?>
        <pub-id pub-id-type="pmid">21305028</pub-id>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Quinlan</surname>
            <given-names>AR</given-names>
          </name>
          <name>
            <surname>Hall</surname>
            <given-names>IM</given-names>
          </name>
        </person-group>
        <article-title>BEDTools: a flexible suite of utilities for comparing genomic features</article-title>
        <source>Bioinformatics</source>
        <year>2010</year>
        <volume>26</volume>
        <fpage>841</fpage>
        <lpage>2</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btq033</pub-id>
        <?supplied-pmid 20110278?>
        <pub-id pub-id-type="pmid">20110278</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Szklarczyk</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Gable</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Lyon</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Junge</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Wyder</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Huerta-Cepas</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets</article-title>
        <source>Nucleic Acids Res</source>
        <year>2019</year>
        <volume>47</volume>
        <fpage>D607</fpage>
        <lpage>13</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gky1131</pub-id>
        <?supplied-pmid 30476243?>
        <pub-id pub-id-type="pmid">30476243</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
